Maria Cinta Cid

Servicio de Enfermedades Autoinmunes Médico internista

Grupo de investigación

Vasculitis sistémicas Group leader (R4)

mccid@clinic.cat 0000-0002-4730-0938

Publicaciones destacadas

Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis

Autores:
Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW;

(...)

Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME .

Referencia: Journal Of Allergy And Clinical Immunology 2019.
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Autores:
Jones RB; Hiemstra TF; Ballarin J; Blockmans DE; Brogan P;

(...)

Walsh D; Walters G; Harper L; Jayne D; European Vasculitis Study Group (EUVAS).

Referencia: Annals Of The Rheumatic Diseases 2019.
Expression and function of IL12/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: Contribution of p40 to Th1-and Th17-mediated inflammatory pathways

Autores:
Espigol-Frigole, Georgina; Planas-Rigol, Ester; Lozano, Ester; Corbera-Bellalta, Marc; Terrades-Garcia, Nekane;

Prieto-Gonzalez, Sergio; Garcia-Martinez, Ana; Hernandez-Rodriguez, Jose; Grau, Josep M; Cid, Maria C.

Referencia: Frontiers In Immunology 2018.
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: A mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

Autores:
Planas-Rigol, Ester; Terrades-Garcia, Nekane; Corbera-Bellalta, Marc; Lozano, Ester; Alba, Marco A;

(...)

Prieto-Gonzalez, Sergio; Hernandez-Rodriguez, Jose; Preciado, Sara; Lavilla, Rodolfo; Cid, Maria C.

Referencia: Annals Of The Rheumatic Diseases 2017.
Trial of Tocilizumab in Giant-Cell Arteritis.

Autores:
Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M;

(...)

Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N .

Referencia: New England Journal Of Medicine 2017.
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Autores:
Wechsler, M E; Akuthota, P; Jayne, D; Khoury, P; Klion, A;

(...)

Philipson, R; Yancey, S W; Steinfeld, J; Weller, P F; Gleich, G J;EGPA Mepolizumab Study Team.

Referencia: New England Journal Of Medicine 2017.
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Autores:
Carmona FD; Vaglio A; Mackie SL; Hernández-Rodríguez J; Monach PA;

(...)

Morgan AW; González-Gay MA; Martín J Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium.

Referencia: American Journal Of Human Genetics 2017.
Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Autores:
Corbera-Bellalta, Marc; Planas-Rigol, Ester; Lozano, Ester; Terrades-Garcia, Nekane; Alba, Marco A;

(...)

Roux-Lombard, Pascale; Ferlin, Walter G; Dayer, Jean-Michel; Kosco-Vilbois, Marie H; Cid, Maria C.

Referencia: Annals Of The Rheumatic Diseases 2016.
Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling

Autores:
Espigol-Frigole, Georgina; Planas-Rigol, Ester; Ohnuki, Hidetaka; Salvucci, Ombretta; Kwak, Hyeongil;

Ravichandran, Sarangan; Luke, Brian; Cid, Maria C; Tosato, Giovanna.

Referencia: Science Signaling 2016.
Changes in biomarkers after therapeutic intervention in temporal arteries cell arteritis

Autores:
Corbera-Bellalta, Marc; Garcia-Martinez, Ana; Lozano, Ester; Planas-Rigol, Ester; Tavera-Bahillo, Itziar;

(...)

Fernandez, Pedro L; Roux-Lombard, Pascale; Dayer, Jean-Michel; Rahman, Mahboob U; Cid, Maria C.

Referencia: Annals Of The Rheumatic Diseases 2014.

Proyectos destacados

Perfil de expresión génica en linfocitos T CD4+ de pacientes con granulomatosis eosinofílica con poliangiítis o Sde. de Churg-Strauss

Investigador/a principal: Georgina Espigol-Frigole, Georgia Espigol-Frigole

Financiador: Instituto de Salud Carlos III (ISCIII)

Código: PI18/00461

Duración: 01/07/2019 - 31/12/2021
Effects of blocking IL-6 receptor with tocilizumab on ex-vivo cultured arteries from patients with giant-cell arteritis. Searching for predictors of response

Investigador/a principal: Maria Cinta Cid Xutgla

Financiador: International vasculitis Foundation

Código: VASCFOUND_RG_18_01

Duración: 01/06/2019 - 31/05/2020
Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET

Investigador/a principal: Maria Cinta Cid Xutgla, Patricia Pérez Galán

Financiador: Ministerio de Economia y Competitividad (MINECO)

Código: SAF 2017- 88275-R

Duración: 01/01/2018 - 31/12/2020
Development of ascending aorta dilatation and coronary aneurysms in patients with systemic vasculitis (giant-cell arteritis and Kawasaki disease respectively). Role of HIF signaling in abnormal vascular remodeling and inflammation

Investigador/a principal: Maria Cinta Cid Xutgla

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundació La Marató de TV3

Código: Marató TV3 2014/201507

Duración: 01/01/2016 - 01/01/2018
Vasculitis de pequeño vaso rodeando una arteria temporal preservada: significado clínico y búsqueda de biomarcadores con utilidad diagnóstica

Investigador/a principal: Georgina Espigol Frigole

Financiador: Instituto de Salud Carlos III (ISCIII)

Código: PI15/00092

Duración: 01/01/2016 - 31/07/2019

Maria Cinta Cid

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Perfil de expresión génica en linfocitos T CD4+ de pacientes con granulomatosis eosinofílica con poliangiítis o Sde. de Churg-Strauss

Effects of blocking IL-6 receptor with tocilizumab on ex-vivo cultured arteries from patients with giant-cell arteritis. Searching for predictors of response

Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET

Development of ascending aorta dilatation and coronary aneurysms in patients with systemic vasculitis (giant-cell arteritis and Kawasaki disease respectively). Role of HIF signaling in abnormal vascular remodeling and inflammation

Vasculitis de pequeño vaso rodeando una arteria temporal preservada: significado clínico y búsqueda de biomarcadores con utilidad diagnóstica

Suscríbete a la Newsletter del Clínic